What Is a Reed-Sternberg Cell? Appearance and Diagnostic Role

What Is a Reed-Sternberg Cell? Appearance and Diagnostic Role

A large, abnormal B-derived lymphocyte strongly associated with classical Hodgkin lymphoma is known as a Reed-Sternberg cell. Its classic form has two nuclei with prominent reddish-pink nucleoli, creating an owl’s-eye appearance. Your pathologist must interpret that appearance within lymph node tissue rather than identify the disease from one cell alone.

This guide explains cell structure, variants, biopsy findings, and diagnostic markers. It gives you the vocabulary to understand a pathology report and the limits of what a single microscope image or stain can establish.

A Rare Abnormal B-Derived Lymphocyte

These cells are not merely large lymphocytes caught during an unusual stage of development. They arise from the abnormal B lymphocyte population associated with classical disease, even though the surrounding lymph node may contain several kinds of inflammatory immune cells.

The B-cell origin links the cell to the immune-system lineage involved in antibody production. That lineage doesn’t mean a Reed-Sternberg cell functions like a normal antibody-secreting B cell. Its growth program and behavior differ, which is why the term “B-derived” is more precise than calling it a typical B cell.

Only one major subtype of Hodgkin lymphoma is called classical Hodgkin lymphoma. Nodular lymphocyte-predominant Hodgkin lymphoma is biologically and diagnostically separate; it contains large LP cells rather than the characteristic population discussed here. This distinction affects both the cell names used in the report and the markers selected for review.

You can compare the main pathological features below:

  • Large size: The abnormal cell is much bigger than most nearby small lymphocytes.
  • B-cell origin: Its lineage connects it with immune-system cells involved in antibody production.
  • Malignant behavior: It belongs to the abnormal proliferating population responsible for the disease.
  • Reactive surroundings: Numerous nearby immune cells respond to the abnormal population.
  • Disease association: It is characteristic of classical disease, not every form of lymphoma.

Classical disease accounts for a relatively small share of all lymphomas, but its tissue pattern is distinctive. Your pathologist cannot diagnose it by counting large cells alone, because their shape, distribution, markers, and relationship to surrounding immune cells all carry information.

The Distinctive Owl’s-Eye Appearance

Two nuclei define the textbook appearance under a light microscope. Each nucleus often contains a prominent eosinophilic nucleolus, which stains reddish-pink in routine laboratory preparation. Viewed together, the paired nuclei and central nucleoli can resemble an owl’s face.

Your slide may not show that symmetrical pattern in every field. Fixation, section thickness, and staining can obscure nuclear detail, while disease subtypes can contain related cells with one nucleus rather than two. This is why “owl’s-eye” is a useful visual description, not a stand-alone diagnostic rule.

A mononuclear Hodgkin cell has one nucleus and lacks the classic paired arrangement. A mummified Hodgkin cell appears shrunken and dark, with condensed nuclear material and less visible internal detail. Each can occur within classical disease even when the two-nucleated form is absent.

A lacunar cell provides another recognizable pattern. During tissue processing, the cell can retract from its surroundings and leave a clear space called a lacuna. That artifact may make the nucleus more prominent even though you don’t see two obvious owl’s-eye nuclei.

The surrounding tissue remains essential. Lymphocytes, eosinophils, plasma cells, histiocytes, and other inflammatory cells often cluster around the abnormal population. This mixed reactive background differs from the uniform sheets of tumor cells seen in many other cancers, so architecture can be as diagnostic as cell shape.

Diagnostic Significance in Classical Hodgkin Lymphoma

The characteristic malignant cell gives your pathologist a central clue to classical disease. Finding a convincing example supports that diagnosis, particularly when the lymph node also shows the expected scattered distribution and mixed inflammatory background.

Picture one large binucleated cell among dozens of small lymphocytes. Its size draws attention, but a single isolated cell cannot establish the diagnosis. Your pathologist must examine nuclear structure, staining, abundance, distribution, and nearby immune cells across multiple tissue areas.

Look-alike cells can occur in infections, inflammatory disorders, and other malignancies. A reactive cell may have two conspicuous nucleoli, while a different cancer may express the same marker proteins. For that reason, neither CD30 positivity nor owl’s-eye morphology is conclusive by itself.

Your pathologist distinguishes a true Reed-Sternberg cell from a look-alike by combining nuclear shape, cell size, staining markers, tissue architecture, and clinical information.

That combined method prevents a common interpretive error: treating an isolated CD30-positive cell as proof of classical disease. A report may use phrases such as “suspicious for” or “differential includes” when the evidence remains incomplete, because several independent features must support the same classification.

How Pathologists Recognize the Cell

Identification starts with a lymph node biopsy or another suitable tissue sample. At low magnification, your pathologist reviews the architecture for enlarged lymphoid areas, scattered large cells, and the distribution of inflammatory cells before moving to finer nuclear detail.

At higher magnification, the evaluation concentrates on nuclear number, nucleoli, cytoplasm, and overall cell shape. A classic example is usually much larger than its neighbors and may have two mirror-like nuclear lobes with large eosinophilic nucleoli. Processing changes can make the cytoplasm look paler or more condensed.

Confidence increases when several fields show a compatible population in a compatible background. A solitary atypical cell produces a different problem: it may represent inflammation, infection, treatment effect, or another neoplasm. Distribution therefore helps determine whether one cell represents the disease’s main abnormal population.

Microscopic Features

Two nuclear lobes and large nucleoli create the familiar owl’s-eye image, while abundant pale cytoplasm helps separate the large cell from nearby lymphocytes. Fixation and tissue processing can distort those details, so your pathologist evaluates preserved features rather than relying on one perfect example.

The abnormal cells are usually scattered through a mixed inflammatory background rather than forming a solid sheet. That architecture reflects the characteristic combination of a limited malignant population and a broader reactive response in classical disease.

Diagnostic Markers

CD30 is a usual marker, and many affected cells also express CD15. Your pathologist interprets these Hodgkin lymphoma diagnostic markers alongside morphology, but staining cannot replace it: CD30 occurs in other conditions, and CD15 is absent from some classical cases.

PAX5 may support B-cell lineage when its staining pattern fits the full panel. Marker results can be partial or atypical, so a negative or unexpected result doesn’t automatically cancel convincing morphology and architecture. Interpretation depends on which markers are positive and where their staining appears.

A Practical Pathology Checklist

Your review depends on five connected observations:

  1. Architecture: Confirm where the abnormal cells sit and how they are distributed within the lymph node.
  2. Morphology: Assess cell size, nuclear count, nucleoli, cytoplasm, and internal detail.
  3. Background: Record the reactive immune cells surrounding the abnormal population.
  4. Markers: Interpret CD30, CD15, PAX5, and other stains within the complete panel.
  5. Clinical fit: Reconcile the biopsy with imaging, blood findings, symptoms, and medical history.

A report may describe “atypical large cells,” “immunoblasts,” or “Hodgkin-like cells” while classification remains under review. Such wording indicates unresolved morphology rather than a final entity. Additional review becomes appropriate when morphology, marker results, and the clinical picture don’t form a clear match.

Reed-Sternberg Cells and Other Hodgkin-Lymphoma Cells

Several related cells occur in classical disease, but each has a distinct appearance or diagnostic setting. Nuclear structure, tissue processing, and marker patterns separate them. The LP or popcorn cell instead belongs to a separate category of disease.

Cell typeTypical appearanceDiagnostic setting
Reed-Sternberg cellLarge cell with two nuclei and prominent nucleoliClassical Hodgkin lymphoma
Mononuclear Hodgkin cellLarge cell with one nucleus and a prominent nucleolusClassical Hodgkin lymphoma variant
Lacunar cellRetraction artifact creates a clear space around the cellClassical Hodgkin lymphoma variant
Mummified Hodgkin cellShrunken, dark, compact cell with condensed nuclear materialClassical Hodgkin lymphoma variant
LP or popcorn cellLarge cell with a multilobed or folded nucleusNodular lymphocyte-predominant Hodgkin lymphoma

The LP cell gets its nickname from a nucleus with several folded lobes. You usually encounter these cells in a nodular growth pattern with numerous small B lymphocytes, rather than the typical background of classical disease. Their marker profile also differs, so they aren’t simply alternate names for the classic binucleated cell.

Your final classification depends on the abnormal population, reactive background, growth pattern, and marker results together. Before assigning a recognized disease category, your pathologist compares all of those observations rather than translating one cell’s nickname into a diagnosis.

Limits of Diagnosis and Pathologist Interpretation

A small proportion of otherwise convincing cases lack clearly identifiable classic cells. You shouldn’t exclude classical disease solely because the textbook form is absent when architecture, marker studies, imaging, and clinical findings support the diagnosis.

This exception can occur because the abnormal cells are scarce, unevenly distributed, or altered during fixation. Your pathologist may examine another part of the specimen, review additional levels, and apply more stains while documenting that classic examples weren’t seen.

Conversely, CD30 expression or a single owl’s-eye cell has limited value by itself. Reactive immune disorders, infection-related findings, and some other cancers can create overlapping clues. Your doctor must compare those findings with the involved location, symptoms, blood counts, imaging, and previous tests.

The practical principle remains stable: your diagnosis rests on tissue examination, careful morphology, marker studies, and supporting clinical information. The characteristic cell is a major clue, not a standalone verdict or a substitute for reviewing the entire specimen.

What to Remember

Your strongest understanding comes from linking appearance with tissue context. The central features work together rather than functioning as separate checklist items:

  • Size and shape: Expect a very large cell with one or two nuclei and prominent nucleoli, without relying on shape alone.
  • Tissue context: Your pathologist assesses the reactive background and the distribution of abnormal cells.
  • Marker pattern: CD30 and CD15 can support the diagnosis, though neither is specific enough to establish it alone.
  • Cell variants: One nucleus, processing artifact, or a shrunken appearance doesn’t necessarily exclude classical disease.
  • Complete interpretation: Morphology, architecture, stains, imaging, and clinical findings guide the final classification.

Keep the original report with any slides, images, and marker results. If the wording remains unclear or doesn’t fit your clinical picture, ask your pathologist which features supported the classification and whether additional review is appropriate.

You can use the report’s terms to follow up more precisely. Questions about a variant, marker, or atypical cell may help clarify whether the diagnosis rests on classic morphology, an uncommon pattern, or supporting molecular and clinical information.

FAQ

What is a Reed-Sternberg cell?

This large, abnormal B-derived lymphocyte is most closely associated with classical Hodgkin lymphoma. Its classic form has two nuclei, each with a prominent nucleolus, creating an owl’s-eye appearance. Your pathologist identifies it through the combined pattern seen in tissue, marker studies, and clinical findings.

Where are Reed-Sternberg cells found?

These cells usually appear in an abnormal lymph node or another involved tissue sample during evaluation for classical Hodgkin lymphoma. Because they are rare among many surrounding reactive immune cells, your pathologist may need to examine several tissue areas before finding a representative example.

Which disease is associated with Reed-Sternberg cells?

That characteristic malignant cells of classical Hodgkin lymphoma. Similar cells can appear in infections, inflammatory conditions, and other cancers, so finding one doesn’t establish classical disease by itself. Your pathologist must consider the broader tissue pattern.

What does a Reed-Sternberg cell look like?

The classic cell is unusually large and often has two nuclei with large reddish-pink nucleoli. That paired structure creates the owl’s-eye description. Variants include mononuclear Hodgkin cells, lacunar cells, and mummified Hodgkin cells, which can look different because of nuclear structure or tissue processing.

How are Reed-Sternberg cells identified in a biopsy?

Your pathologist examines lymph node architecture, cell morphology, and the surrounding inflammatory cells. CD30 is a usual marker, and many cells also express CD15. PAX5 and other markers may add support. The final interpretation combines tissue appearance, staining results, imaging, and your clinical information.

Are Reed-Sternberg cells present in every case of Hodgkin lymphoma?

No. Classical disease is closely associated with these cells and their variants. Nodular lymphocyte-predominant disease instead contains LP, or popcorn, cells. Even within classical disease, a small proportion of cases may lack clearly identifiable classic examples because the abnormal cells are scarce or altered.

Staff
Staff

Our team brings together health and food enthusiasts who are passionate about discovering reliable health information, nutritious choices, and enjoyable food experiences. From everyday nutrition and healthy eating ideas to recipes, ingredients, food trends, and standout dishes, we share carefully researched and thoughtfully curated content to help readers make informed choices about what they eat and enjoy.